NEW YORK, July 31, 2012 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that poster ...
Synergy Pharmaceuticals, Inc. (SGYP) To Present Scientific Poster At 2012 Advances In IBD Conference
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Today, Synergy Pharmaceuticals announced that it will make a poster presentation on SP-333, its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results